Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expression
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Background: There is a significant need for reliable molecular biomarkers to aid in Alzheimer's disease (AD) clinical diagnosis. Methods: We performed a genome‐wide investigation of the human transcriptome, taking into account the discriminatory power of splice variations from the blood of 80 AD patients and 70 nondemented control (NDC) individuals. Results: We characterized a blood RNA signature composed of 170 oligonucleotide probe sets associated with 133 genes that can correctly distinguish AD patients from NDC with a sensitivity of 100% and specificity of 96%. Functionally, this signature highlights genes involved in pathways that were associated with macrophages and lymphocytes within AD patients: Transforming growth factor (TGF‐β) signaling, oxidative stress, innate immunity and inflammation, cholesterol homeostasis, and lipid‐raft perturbation, whereas other genes may also provide new insights in the biology of AD. Conclusions: This study provides proof‐of‐concept that whole‐blood profiling can generate an AD‐associated classification signature via the specific relative expression of biologically relevant RNAs. Such a signature will need to be validated with extended patient cohorts, and evaluated to learn whether it can differentiate AD from others types of dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
MAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126 · cited 1×
“Its performances were measured against standards recently described for microarray quality control [12], and were found to be similar to the expression platforms reported in the Microarray Quality Control Study [13; personal communication, W.”
ResultClassification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048 · cited 1×
“Recently, a set of 18 signaling plasma proteins was shown to classify AD and control individuals at nearly 90% accuracy [55].”
BackgroundVariation in alternative splicing across human tissues
Yeo, G., Holste, D., Kreiman, G., & Burge, C. B. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r74 · Cited by 584 · cited 1×
“Brain is one of the most prominent human tissues with respect to splice-variant diversity [5].”
BackgroundNeuronal regulation of alternative pre-mRNA splicing
Li, Q., Lee, J.-A., & Black, D. L. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2237 · Cited by 376 · cited 1×
“A recent review described some of the mechanisms and the functional relevance of alternative splicing within genes expressed in the nervous system [6].”
BackgroundGene expression changes in children with autism
Gregg, J. P., Lit, L., Baron, C. A., Hertz-Picciotto, I., Walker, W., Davis, R. A., Croen, L. A., Ozonoff, S., Hansen, R., Pessah, I. N., et al. (2008) · Genomics · doi:10.1016/j.ygeno.2007.09.003 · Cited by 181
Using RNA sample titrations to assess microarray platform performance and normalization techniques
Shippy, R., Fulmer-Smentek, S., Jensen, R. V., Jones, W. D., Wolber, P. K., Johnson, C. D., Pine, P. S., Boysen, C., Guo, X., Chudin, E., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1241 · Cited by 173
Hoe, H.-S., Wessner, D., Beffert, U., Becker, A. G., Matsuoka, Y., & Rebeck, G. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9259-9268.2005 · Cited by 122
Ma, S. L., Ng, H. K., Baum, L., Pang, J. C. S., Chiu, H. F. K., Woo, J., Tang, N. L. S., & Lam, L. C. W. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00942-4 · Cited by 39 · cited 1×
“Finally, the signature includes the low-density lipoprotein receptor-related protein 8 (LRP8), a receptor for ApoE that mediates lipids and cholesterol transport, and for which a specific allele predisposes carriers to the common late-onset form of AD [30].”
Background
Cited by
Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease
Lunnon, K., Smith, R., Hannon, E., De Jager, P. L., Srivastava, G., Volta, M., Troakes, C., Al-Sarraj, S., Burrage, J., Macdonald, R., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3782 · Cited by 574
del Campo, M., Mollenhauer, B., Bertolotto, A., Engelborghs, S., Hampel, H., Simonsen, A. H., Kapaki, E., Kruse, N., Le Bastard, N., Lehmann, S., et al. (2012) · Biomarkers in Medicine · doi:10.2217/bmm.12.46 · Cited by 343
Rahman, M. R., Islam, T., Zaman, T., Shahjaman, M., Karim, M. R., Huq, F., Quinn, J. M. W., Holsinger, R. M. D., Gov, E., & Moni, M. A. (2020) · Genomics · doi:10.1016/j.ygeno.2019.07.018 · Cited by 136
Concerted Perturbation Observed in a Hub Network in Alzheimer’s Disease
Liang, D., Han, G., Feng, X., Sun, J., Duan, Y., & Lei, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040498 · Cited by 93
“Alternative splicing of ACTB and UBQLN4 was found in a splicing-dedicated microarray study of AD [67].”
BackgroundLunnon, K., & Mill, J. (2013) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32201 · Cited by 78
“…a number of transcriptomic biomarkers for AD have already been developed, with specific clinical utility for the early diagnosis of the disease [Fehlbaum-Beurdeley et al., 2010; Booij et al., 2011; Rye et al., 2011; Lunnon et al., 2013], and monitoring drug response in clinical trials…”
Metadata
- Authors
- Fehlbaum-Beurdeley, P., Jarrige-Le Prado, A. C., Pallares, D., Carrière, J., Guihal, C., Soucaille, C., Rouet, F., Drouin, D., Sol, O., Jordan, H., Wu, D., Lei, L., Einstein, R., Schweighoffer, F., & Bracco, L.
- Venue
- Alzheimer's & Dementia
- Publisher
- Wiley
- Published
- 2010-01
- Volume
- 6
- Issue
- 1
- Pages
- 25-38
- ISSN
- 1552-5260 (ISSN-L)
- 1552-5279
- OpenAlex
- W2020706332
- Cited by
- 75
- References
- 9
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expression. https://app.cochat.ai/papers/10.1016/j.jalz.2009.07.001
- The paper
- Fehlbaum-Beurdeley, P., Jarrige-Le Prado, A. C., Pallares, D., Carrière, J., Guihal, C., Soucaille, C., Rouet, F., Drouin, D., Sol, O., Jordan, H., Wu, D., Lei, L., Einstein, R., Schweighoffer, F., & Bracco, L. (2010). Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expression. Alzheimer's & Dementia. https://doi.org/10.1016/j.jalz.2009.07.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.